![](/img/cover-not-exists.png)
Abstract: P391 EFFECTS OF COMBINATION THERAPY OF FLUVASTATIN/FENOFIBRATE VERSUS SIMVASTATIN/EZETIMIBE ON LDL-SUBFRACTIONS IN PATIENTS WITH THE METABOLIC SYNDROME
Winkler, K, Schewe, T, Pütz, G, Ödünc, N, Siegel, E, Abletshauser, C, Hoffmann, MVolume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(09)70686-5
Date:
June, 2009
File:
PDF, 78 KB
english, 2009